CRIS Current Research Information System

DURANTE, SANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.696
AS - Asia 2.305
EU - Europa 1.896
AF - Africa 253
SA - Sud America 103
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.667
VN - Vietnam 686
CN - Cina 612
SG - Singapore 590
GB - Regno Unito 451
IT - Italia 320
SE - Svezia 298
DE - Germania 258
HK - Hong Kong 124
FR - Francia 111
RU - Federazione Russa 102
IN - India 97
NL - Olanda 78
IE - Irlanda 72
BR - Brasile 63
CI - Costa d'Avorio 62
CH - Svizzera 57
TG - Togo 51
ZA - Sudafrica 50
NG - Nigeria 49
EE - Estonia 33
UA - Ucraina 33
FI - Finlandia 32
JO - Giordania 31
JP - Giappone 29
IR - Iran 28
SC - Seychelles 27
CA - Canada 21
AR - Argentina 18
ID - Indonesia 15
BD - Bangladesh 13
PH - Filippine 13
BG - Bulgaria 11
BE - Belgio 10
IQ - Iraq 10
TH - Thailandia 10
PL - Polonia 8
MX - Messico 7
CO - Colombia 6
KR - Corea 6
PK - Pakistan 6
TR - Turchia 6
UZ - Uzbekistan 6
CL - Cile 5
AU - Australia 4
LB - Libano 4
SA - Arabia Saudita 4
TW - Taiwan 4
AT - Austria 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EC - Ecuador 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AL - Albania 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
GY - Guiana 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
Totale 7.259
Salva come PNG Salva come JPEG
Città #
Singapore 409
Southend 406
Ashburn 354
Chandler 249
Fairfield 233
Ho Chi Minh City 138
Beijing 121
Hong Kong 119
Houston 118
Santa Clara 114
Hanoi 109
Woodbridge 108
San Jose 105
Wilmington 105
Seattle 102
Ann Arbor 92
Princeton 91
Dong Ket 84
Dallas 76
Cambridge 74
Dublin 72
Abidjan 62
Bern 56
Bologna 52
Lomé 51
New York 51
Boardman 46
Nanjing 45
Pavia 45
Lauterbourg 41
Padova 40
Westminster 40
Los Angeles 32
Amman 30
Frankfurt am Main 30
Jinan 29
Abeokuta 27
Helsinki 27
Nanchang 26
Medford 25
Shenyang 23
Berlin 22
Haiphong 22
Tokyo 22
Saint Petersburg 20
Munich 18
Milan 17
Tianjin 17
Bremen 16
Buffalo 16
Guangzhou 16
Hebei 16
Washington 16
San Diego 15
Johannesburg 14
Turin 14
Da Nang 13
Kuban 13
Redondo Beach 12
Changsha 11
Falkenstein 11
Florence 11
Hangzhou 11
Sofia 11
Tehran 11
Tongling 11
Brussels 10
Chengdu 10
Council Bluffs 10
Igea Marina 10
Toronto 10
Falls Church 9
São Paulo 9
Pune 8
Rome 8
Shanghai 8
Biên Hòa 7
Calderara Di Reno 7
Jakarta 7
Jiaxing 7
Redwood City 7
Zhengzhou 7
Denver 6
Hải Dương 6
Jacksonville 6
Bühl 5
Bến Tre 5
Can Tho 5
Haikou 5
Lanzhou 5
Mülheim 5
Ningbo 5
Orem 5
Redmond 5
San Mateo 5
Shenzhen 5
Turku 5
Wuhan 5
Yubileyny 5
Amsterdam 4
Totale 4.659
Salva come PNG Salva come JPEG
Nome #
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 267
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in Chronic Myelogenous Leukemia CD34+ hematopoietic progenitor cells 260
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 253
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 229
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS 221
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 220
Chondrogenic differentiation of human adipose mesenchimal stem cells: Influence of a biomimetic gelatin genipin crosslinked porous scaffold 217
Simulating tumor microenvironment: changes in protein expression in an in vitro co-culture system. 216
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold 212
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 209
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. 208
Gelatin crosslinked with dehydroascorbic acid as a novel scaffold for tissue regeneration with simultaneous antitumor activity. 203
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. 197
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression 197
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 190
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 189
De-Regulation of Extracellular Matrix Proteins in Human Fibroblasts after Long-term and Low Concentrations of HEMA Exposition 185
Matricellular protein expression as a new parameter to test in vitro cytotoxicity of a 3D biomimetic material 185
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 183
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 182
Matricellular Protein Expression and Cell Ultrastructure as Parameters to Test In Vitro Cytotoxicity of a Biomimetic Scaffold 177
State of the art biological therapies in pancreatic cancer 177
A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM) 174
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 172
Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide 169
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. 167
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold 166
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 165
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients 163
GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS 157
In vitro osteogenic and odontogenic differentiation of human dental pulp stem cells seeded on carboxymethyl cellulose-hydroxyapatite hybrid hydrogel 157
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 153
Osteochondral tissue engineering strategies: the role of stem cell source 148
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients 143
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients 139
Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients. 125
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients 125
IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME 123
Frontline Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: a Phase 2 Multicentric Study 120
NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: BEYOND 4 YEARS RESULTS REMAIN STABLE - THE GIMEMA CML WP TRIAL CML0307 110
Proteasome inhibitors: Bortezomib in multiple myeloma 91
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation 61
Totale 7.405
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.426
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021314 0 0 0 0 0 0 0 0 0 27 45 242
2021/2022837 60 34 28 58 75 69 9 37 37 140 130 160
2022/20231.073 91 178 48 147 69 77 27 60 178 28 77 93
2023/2024386 20 56 25 37 39 120 21 19 8 10 10 21
2024/2025923 42 120 68 77 157 58 57 50 8 94 35 157
2025/20262.035 163 137 209 111 304 120 273 55 501 162 0 0
Totale 7.405